Abstract
This is a retrospective study including 17 patients with rhino-orbito-cerebral mucormycosis diagnosed in a period of 16 years, between 1992 and 2007, in 8 men and 9 women. All patients were diabetic with ketoacidosis diabetes in 8 cases. Necrosis facial and ophthalmic symptoms were the most frequent presenting manifestations. The diagnosis was confirmed by mycological examination, with or without histopathology, identifying Rhizopus oryzae in 12 cases. Treatment consisted in systemic amphotericin B combined with surgical treatment in only 7 cases. The mortality rate was high (65%) due principally to the delay in diagnosis and absence of surgical treatment.
MeSH terms
-
Amphotericin B / therapeutic use*
-
Antifungal Agents / therapeutic use
-
Diabetes Complications / drug therapy
-
Diabetes Complications / microbiology*
-
Diabetes Complications / pathology
-
Diabetes Complications / surgery
-
Diabetic Ketoacidosis / drug therapy
-
Diabetic Ketoacidosis / pathology
-
Female
-
Humans
-
Male
-
Mucormycosis / complications*
-
Mucormycosis / drug therapy
-
Mucormycosis / pathology
-
Mucormycosis / surgery
-
Nose Diseases / drug therapy
-
Nose Diseases / microbiology
-
Nose Diseases / pathology
-
Nose Diseases / surgery
-
Orbital Diseases / drug therapy
-
Orbital Diseases / microbiology
-
Orbital Diseases / pathology
-
Orbital Diseases / surgery
-
Paranasal Sinus Diseases / drug therapy
-
Paranasal Sinus Diseases / microbiology
-
Paranasal Sinus Diseases / pathology
-
Paranasal Sinus Diseases / surgery
-
Retrospective Studies
-
Rhizopus / isolation & purification
-
Tunisia / epidemiology
Substances
-
Antifungal Agents
-
Amphotericin B